(Q52889999)

English

Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.

scientific article published in August 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra. (English)

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

substantia nigra

1 reference

based on heuristic

inferred from title

author name string

Andringa G

1

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

van Oosten RV

2

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

Unger W

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

Hafmans TG

4

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

Veening J

5

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

Stoof JC

6

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

Cools AR

7

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

European Journal of Neuroscience

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

12

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

8

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

3033-3043

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Selegiline in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

The flexible use of multiple cue relationships in spatial navigation: a comparison of water maze performance following hippocampal, medial septal, prefrontal cortex, or posterior parietal cortex lesions.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Role of the neostriatal dopaminergic activity in sequencing and selecting behavioural strategies: facilitation of processes involved in selecting the best strategy in a stressful situation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Role of neostriatum and nucleus accumbens in stepping induced by apomorphine and dexamphetamine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

The Paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Pars compacta of the substantia nigra modulates motor activity but is not involved importantly in regulating food and water intake

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Oxidative stress and the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Clinical pharmacokinetics and pharmacodynamics of selegiline. An update

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Selegiline: current perspectives on issues related to neuroprotection and mortality

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

An interim report of the effect of selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease. The Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Formation of a place learning-set by the rat: a new paradigm for neurobehavioral studies.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Impairments and compensation in mouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Dopamine depletion, stimulation or blockade in the rat disrupts spatial navigation and locomotion dependent upon beacon or distal cues.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Neurochemical Compensation After Nigrostriatal Bundle Injury in an Animal Model of Preclinical Parkinsonism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2000.00181.X

21 January 2018

Identifiers

10.1046/J.1460-9568.2000.00181.X

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/10971644

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52889999&oldid=1250873200"